Healthcare

Facing the impending loss of patent protection for its key immunology drug Stelara, Johnson & Johnson is strategically bolstering its...

A significant shift in its market listing underscores the current difficulties for Carl Zeiss Meditec. The medical technology firm is...

The investment case for Swiss pharmaceutical giant Roche presents a complex picture, marked by promising clinical developments in one area...

The biopharmaceutical company Outlook Therapeutics is approaching a pivotal transition, moving from clinical development into the commercial phase. This shift...

UnitedHealth Group finds itself at a pivotal juncture, balancing shareholder returns with strategic flexibility as it undertakes a significant operational...

As it approaches the fifth anniversary of its privatization, North American optical retail leader New Look Vision is entering a...

FutureGen Industries has announced the successful completion of several divestments within its healthcare portfolio, generating substantial capital gains. The proceeds...

Following prominent presentations at recent major healthcare conferences, the clinical progress of Olema Pharmaceuticals has captured significant market attention. The...

The stock of Greenwich Lifesciences Inc finds itself in a holding pattern. In the absence of concrete news regarding fresh...

Following the close of its 2025 fiscal year, Solventum is accelerating its push toward full independence. The firm is now...